Nationwide Increasing Incidence of Nontuberculous Mycobacterial Diseases Among Adults in Denmark: Eighteen Years of Follow-Up
- PMID: 38499239
- DOI: 10.1016/j.chest.2024.03.023
Nationwide Increasing Incidence of Nontuberculous Mycobacterial Diseases Among Adults in Denmark: Eighteen Years of Follow-Up
Abstract
Background: The epidemiology of nontuberculous mycobacteria (NTM) infections is not well described. In this study, we sought to determine the incidence and prevalence of NTM infections and focus on social risk factors. In addition, we describe people with pulmonary and extrapulmonary NTM.
Research question: What are the incidence and prevalence of NTM in Denmark, and what are the characteristics of the affected patients?
Study design and methods: This is a nationwide retrospective register-based cohort study in Denmark. Adult patients in the Danish national registers who received a diagnosis of NTM disease from 2000 to 2017 were classified as having either pulmonary or extrapulmonary NTM disease.
Results: We identified 1,146 adults with an NTM diagnosis. Of these, 661 patients had pulmonary NTM, of whom 50.4% were male, whereas 485 had extrapulmonary NTM, of whom 59.6% were male. The median age (interquartile range) was 66 (18) years and 57 (32) years, respectively. The yearly incidence rate per 100,000 increased between 2000 and 2017 for both pulmonary NTM (0.4 to 1.3) and extrapulmonary NTM (0.3 to 0.6). The annual prevalence per 100,000 inhabitants increased from 0.4 to 3.5 for pulmonary NTM and from 0.3 to 1.0 for extrapulmonary NTM. The incidence rate increased with age. The incidence of pulmonary NTM was highest among those who were aged 70 years or older (19.3 per 100,000 inhabitants). Compared with patients with pulmonary NTM, patients with extrapulmonary NTM were more likely to be employed and had a higher educational level.
Interpretation: This study indicates that the prevalence of NTM disease in Denmark increased between 2000 and 2017. We found that patients with pulmonary NTM and patients with extrapulmonary NTM represent two distinct groups that differ in age, sex, education, and employment status. Increased suspicion of pulmonary NTM disease is warranted in older adults after exclusion of more common lung infections.
Keywords: epidemiology; nontuberculous mycobacteria; nontuberculous mycobacterial disease; nontuberculous mycobacterial extrapulmonary disease; nontuberculous mycobacterial pulmonary disease.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: A. A. P. participates in an advisory board for Nordicinfu Care Denmark, which distributes ARIKAYCE (amikacin liposome inhalation suspension) for Insmed. A. F. participates in an advisory board for Nordicinfu Care Denmark, which distributes ARIKAYCE (amikacin liposome inhalation suspension) for Insmed. None declared (A. L., R. I., I. S. J., O. H.).
Similar articles
-
Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.Ann Am Thorac Soc. 2015 May;12(5):642-7. doi: 10.1513/AnnalsATS.201412-559OC. Ann Am Thorac Soc. 2015. PMID: 25692495 Free PMC article.
-
Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.Ann Am Thorac Soc. 2018 Jul;15(7):817-826. doi: 10.1513/AnnalsATS.201709-727OC. Ann Am Thorac Soc. 2018. PMID: 29897781 Free PMC article.
-
Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.Ann Am Thorac Soc. 2019 Mar;16(3):341-347. doi: 10.1513/AnnalsATS.201806-366OC. Ann Am Thorac Soc. 2019. PMID: 30339468
-
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8. Respir Med. 2019. PMID: 31128614 Review.
-
Management Challenges of Extrapulmonary Nontuberculous Mycobacterial Infection: A Single-Center Case Series and Literature Review.Pathogens. 2023 Dec 21;13(1):12. doi: 10.3390/pathogens13010012. Pathogens. 2023. PMID: 38276158 Free PMC article. Review.
Cited by
-
Pulmonary Delivery of Antibiotics to the Lungs: Current State and Future Prospects.Pharmaceutics. 2025 Jan 15;17(1):111. doi: 10.3390/pharmaceutics17010111. Pharmaceutics. 2025. PMID: 39861758 Free PMC article. Review.
-
Diagnostics, resistance and clinical relevance of non-tuberculous mycobacteria unidentified at the species level by line probe assays: a bi-national study.Ann Clin Microbiol Antimicrob. 2025 Feb 17;24(1):14. doi: 10.1186/s12941-025-00781-z. Ann Clin Microbiol Antimicrob. 2025. PMID: 39962513 Free PMC article.
-
NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.Int J Mol Sci. 2025 Jan 29;26(3):1155. doi: 10.3390/ijms26031155. Int J Mol Sci. 2025. PMID: 39940923 Free PMC article.
-
Mortality Rate and Cause of Death in Adults with Extrapulmonary Nontuberculous Mycobacteria Infection, Denmark.Emerg Infect Dis. 2024 Sep;30(9):1790-1798. doi: 10.3201/eid3009.240475. Emerg Infect Dis. 2024. PMID: 39173661 Free PMC article.
-
Extrapulmonary Nontuberculous Mycobacteria Infection: The New-Age Neglected Infectious Disease.Cureus. 2025 Mar 22;17(3):e81017. doi: 10.7759/cureus.81017. eCollection 2025 Mar. Cureus. 2025. PMID: 40264600 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical